Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1998
03/19/1998WO1998011245A1 Sustained delivery device and methods of making and using the same
03/19/1998WO1998011244A2 Aav4 vector and uses thereof
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011242A2 Neurological disease model
03/19/1998WO1998011241A1 Oligocistronic expression system for the production of heteromeric proteins
03/19/1998WO1998011240A2 A process of increasing plant growth and yield and modifiying cellulose production in plants
03/19/1998WO1998011239A1 REGULATORY SEQUENCE OF CELLULASE cbh1 GENES ORIGINATING IN TRICHODERMA VIRIDE AND SYSTEM FOR MASS-PRODUCING PROTEINS OR PEPTIDES THEREWITH
03/19/1998WO1998011238A2 Protease m, a novel serine protease
03/19/1998WO1998011237A1 Self-secreting proteases
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011235A2 Transgenic plants expressing cellulolytic enzymes
03/19/1998WO1998011234A2 Human protein kinases
03/19/1998WO1998011233A1 Novel human phosphorylase kinase gamma subunit
03/19/1998WO1998011231A1 Highly regulable promoter for heterologous gene expression
03/19/1998WO1998011230A1 Polyketide synthases for pradimicin biosynthesis and dna sequences encoding same
03/19/1998WO1998011229A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998WO1998011228A2 Genetic control of fruit ripening
03/19/1998WO1998011227A1 Granulocyte chemotactic protein 2 variant
03/19/1998WO1998011226A2 Mammalian chemokines, related reagents
03/19/1998WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same
03/19/1998WO1998011224A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
03/19/1998WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998WO1998011222A1 Screening methods for compounds useful in the treatment of schizophrenia
03/19/1998WO1998011221A2 Car, a novel coxsackievirus and adenovirus receptor
03/19/1998WO1998011220A2 Novel human cell division cycle proteins
03/19/1998WO1998011219A1 Disease associated membrane protein (damp)
03/19/1998WO1998011218A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
03/19/1998WO1998011217A2 HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS
03/19/1998WO1998011216A1 Novel semaphorin gene: semaphorin y
03/19/1998WO1998011215A1 Human type-i membrane protein and dna encoding this protein
03/19/1998WO1998011214A1 Mammalian and human rec2
03/19/1998WO1998011213A1 Method for treating amyotrophic lateral sclerosis
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011211A2 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES
03/19/1998WO1998011208A1 Method for preparing a plasmid dna
03/19/1998WO1998011207A2 Assays for regulators of mammalian telomerase expression
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011205A2 Materials and methods for the modification of plant lignin content
03/19/1998WO1998011204A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998WO1998011203A1 Cells having dna insertion mutations which produce altered amounts of a polypeptide
03/19/1998WO1998011202A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998WO1998011139A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
03/19/1998WO1998011133A1 New picornaviruses, vaccines and diagnostic kits
03/19/1998WO1998011127A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998WO1998011117A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998WO1998011104A1 Heterocyclic compounds and their use for isolating nucleic acids
03/19/1998WO1998010796A1 Compositions and methods for pulmonary gene delivery
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010788A1 Staphylococcus aureus antigen
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010780A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
03/19/1998WO1998010777A1 Nucleosome-based anti-tumor compositions
03/19/1998WO1998010750A2 Nucleic acid particle delivery
03/19/1998WO1998010748A1 Liposomes
03/19/1998WO1998010734A2 MsENOD40 PROMOTER COMPOSITIONS AND METHODS OF USE
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998WO1998005777A3 BCL-xη, A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO
03/19/1998WO1998002554A3 Cytochrome P450 expression in enterobacteria
03/19/1998WO1998000541A3 Methods for administration of recombinant gene delivery vehicles for treatment of human disease
03/19/1998WO1997048814A3 Methods for the production of stably-transformed, fertile wheat employing agrobacterium-mediated transformation and compositions derived therefrom
03/19/1998WO1997038110A3 Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases
03/19/1998DE19700844A1 Nematodenresistenzgen Nematodenresistenzgen
03/19/1998DE19638044A1 Immunogene Peptide von Maul- und Klauenseuchen-Viren Immunogenic peptides of foot-and-mouth disease virus
03/19/1998DE19637042A1 Heterocyclische Verbindungen und deren Verwendung in der Detektion von Nucleinsäuren Heterocyclic compounds and their use in the detection of nucleic acids
03/19/1998DE19633427A1 Synthesis of nucleic acid molecules
03/19/1998CA2698393A1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) 1 alpha (.alpha.), hnf-1.beta. and hnf-4.alpha.
03/19/1998CA2266123A1 Method for preparing a plasmid dna
03/19/1998CA2265933A1 Sustained delivery device and methods of making and using the same
03/19/1998CA2265929A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2265925A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998CA2265923A1 Human proteins having secretory signal sequences and dnas encoding these proteins
03/19/1998CA2265913A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998CA2265887A1 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2265838A1 Compositions and methods for pulmonary gene delivery
03/19/1998CA2265727A1 Heterocyclic compounds and their use for isolating nucleic acids
03/19/1998CA2265670A1 Nucleosome-based anti-tumor compositions
03/19/1998CA2265524A1 Self-secreting proteases
03/19/1998CA2265503A1 Human type-i membrane protein and dna encoding this protein
03/19/1998CA2265492A1 Mammalian and human rec2
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2265460A1 Aav4 vector and uses thereof
03/19/1998CA2265455A1 Granulocyte chemotactic protein 2 variant
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998CA2264957A1 A process of increasing plant growth and yield and modifying cellulose production in plants
03/19/1998CA2264825A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2264563A1 Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
03/19/1998CA2264545A1 Novel human phosphorylase kinase gamma subunit
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2262505A1 Genetic control of fruit ripening
03/19/1998CA2259283A1 Method for treating amyotrophic lateral sclerosis
03/18/1998EP0829542A1 Method for amplification of nucleic acids
03/18/1998EP0829540A1 Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor
03/18/1998EP0829539A2 Cytoplasmic male sterility dna factor and utilization thereof
03/18/1998EP0829538A2 Peptidoglycan recognition proteins and their production
03/18/1998EP0829537A1 Pearl protein (nacrein) and process for producing the same
1 ... 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 ... 4023